相关实验视频
Updated: Jun 5, 2025

09:41
Performing and Processing FNA of Anterior Fat Pad for Amyloid
Published on: October 30, 2010
55.1K
初级系统性粉样性粉症:简要概述
Michael Sang Hughes1, Suzanne Lentzsch1
1Department of Hematology/Oncology, Columbia University Irving Medical Center, 161 Fort Washington Avenue, 6GN-435, New York, NY 10032, United States of America.
概括
轻链 (AL) 氨基粉症是一种罕见的疾病,其中异常蛋白质会损害器官. 本综述涵盖了其原因,诊断,治疗和正在进行的研究,以改善患者的治疗结果.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 初级系统性氨基粉症或轻链 (AL) 氨基粉症是一种罕见的淋巴增殖性疾病.
- 异常轻链免疫球蛋白聚合成纤维,沉积在组织中并导致器官损伤.
- 未经治疗的AL氨基粉症是致命的,需要全面的理解和管理.
研究的目的:
- 提供AL氨基粉症的全面摘要.
- 审查病理生理学,临床表现和诊断方法.
- 概述目前的治疗策略和新兴的研究领域.
主要方法:
- 关于原发性全身性粉症的文献综述.
- 综合有关病理生理学和临床表现的信息.
- 诊断标准和治疗指南的总结.
主要成果:
- AL粉样性粉症是由错误折叠的免疫球蛋白轻链的沉积引起的.
- 诊断包括识别潜在的血细胞克隆,并评估器官参与.
- 治疗的目的是减少轻链的产生和管理器官功能障碍.
结论:
- 粉样粉症是一种复杂的系统性疾病,需要多学科的管理.
- 早期诊断和适当的治疗对于改善患者的生存率和生活质量至关重要.
- 目前正在进行的研究重点是新的治疗点和改进的诊断工具.
相关概念视频
Amyloid Fibrils
5.1K
5.1K
Alzheimer's Disease: Overview
447
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
447
Parkinson's Disease: Overview
479
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
479
Myasthenia Gravis: Overview and Treatment
1.2K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Primary Lymphoid Organs
1.4K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
1.4K

